Salmon Gill Poxvirus: Veterinary Reference

Introduction

Salmon Gill Poxvirus (SGPV) is an emerging viral pathogen of farmed Atlantic salmon (Salmo salar) that primarily targets gill epithelium, causing proliferative and necrotic gill lesions. The virus belongs to the family Poxviridae and is classified within the subfamily Chordopoxvirinae, although its precise genus placement remains under investigation. SGPV has been implicated in multifactorial gill disease complexes, particularly in marine net-pen production systems, where co-infections with other pathogens and environmental stressors exacerbate clinical outcomes. This reference provides a detailed veterinary and molecular overview of SGPV, including its virological properties, host interactions, diagnostic approaches, and control strategies. The article draws on standard fish virology and aquaculture medicine textbooks for foundational knowledge [1, 2].

Etiology and Taxonomy

Poxviruses are large, double-stranded DNA (dsDNA) viruses that replicate in the cytoplasm of host cells. SGPV exhibits typical poxvirus morphology with an ovoid or brick-shaped virion measuring approximately 200–350 nm in length and 140–260 nm in width, as observed by transmission electron microscopy. The virion contains a complex outer envelope with surface tubules and a central core that houses the linear dsDNA genome. SGPV shares genomic organization features with other chordopoxviruses, including a conserved central region encoding replication and structural proteins, flanked by variable terminal regions that encode host range and immunomodulatory factors [1]. The complete genome of SGPV has been sequenced from isolates obtained from diseased Atlantic salmon in Norway, Scotland, and Canada, revealing a genome size of approximately 210–220 kbp with >150 predicted open reading frames. Phylogenetic analyses place SGPV in a distinct clade within the Chordopoxvirinae, most closely related to fish-associated poxviruses such as Cyprinid herpesvirus-like poxviruses and the Carp edema virus lineage, though formal taxonomic assignment awaits International Committee on Taxonomy of Viruses (ICTV) ratification [2].

Morphology and Genomic Architecture

SGPV virions are enveloped and pleomorphic, though predominantly ovoid. The outer envelope is derived from host cell membrane modified by viral proteins. The core contains a biconcave nucleoprotein complex that includes the linear dsDNA genome and associated viral enzymes such as DNA-dependent RNA polymerase, poly(A) polymerase, and capping enzymes required for early gene transcription. The genome is characterized by inverted terminal repeats (ITRs) and hairpin loops at each end, a feature common to poxviruses. The central conserved region of the genome encodes enzymes involved in DNA replication (e.g., DNA polymerase, helicase, primase) and transcription (e.g., RNA polymerase subunits, transcription factors). The terminal variable regions encode proteins involved in host range determination, immune evasion (e.g., complement control proteins, cytokine binding factors), and virulence. SGPV encodes a unique set of genes not found in terrestrial poxviruses, likely reflecting adaptation to the aquatic host environment and teleost immune system [2].

Host Range and Susceptibility

SGPV has been predominantly detected in farmed Atlantic salmon (Salmo salar). Experimental infections have confirmed replication in salmon gill epithelial cells both in vivo and in primary gill cell cultures. Rainbow trout (Oncorhynchus mykiss) and brown trout (Salmo trutta) appear resistant or show only subclinical infection under experimental conditions [1]. Natural infections have not been reported in non-salmonid fish species in the wild or in aquaculture. The virus appears to have a narrow host range, likely restricted to Salmoninae. Age susceptibility is highest in post-smolts during the first 6 months after transfer to seawater, although outbreaks have been documented in both smolt and adult stages. Stressors such as high water temperature, low dissolved oxygen, elevated ammonia, and handling have been associated with increased clinical severity [2].

Clinical Signs and Pathogenesis

The primary target organ for SGPV is the gill. Infected fish develop multifocal to coalescing white or pale patches on the gill filaments, often described as "proliferative gill disease" like lesions. Histopathological examination reveals gill epithelial hyperplasia, fusion of secondary lamellae, and necrosis of pillar cells and chloride cells. In severe cases, the entire gill arch may become encased in hyperplastic tissue, leading to respiratory compromise. Vesicular or vacuolar changes in gill epithelial cells are sometimes observed, with intracytoplasmic inclusion bodies (Bollinger bodies) visible under light microscopy in some cases [1].

Clinical signs include rapid opercular movements ("pumping"), lethargy, anorexia, and aggregation at the water surface or inlet. Mortality rates vary widely, ranging from 5% to 50%, depending on concurrent infections, water quality, and management conditions. Subclinical infections are common and may serve as reservoirs for transmission. Co-infections with other gill pathogens such as Neoparamoeba perurans (amoebic gill disease), Ichthyobodo spp., Tenacibaculum spp., and Atlantic salmon reovirus (ASRV) are frequently observed and may exacerbate pathology [1, 2].

The pathogenesis involves direct cytopathic effects on gill epithelial cells, leading to loss of barrier function and ionoregulatory disturbance. Viral immune evasion mechanisms include inhibition of interferon responses and modulation of apoptosis pathways, facilitating persistent infection. The PAMP (pathogen-associated molecular pattern) recognition by teleost Toll-like receptors (TLRs) and subsequent inflammatory cytokine cascade contribute to the hyperplastic response [2].

Transmission and Epidemiology

Transmission occurs horizontally via waterborne virus shed from infected fish into the surrounding water. The virus is shed primarily from gill lesions and possibly from skin or feces, though the latter routes are less characterized. The virus can survive in seawater for several days depending on temperature and UV exposure. Mechanical vectors such as sea lice (Lepeophtheirus salmonis) have been hypothesized to play a role in transmission, though evidence is circumstantial. For information on sea lice biology and management, refer to Sea Lice Infestation in Salmon Aquaculture [1].

Epidemiological studies have identified risk factors including high stocking density, poor water quality, presence of organic load, and co-infections with other pathogens. The virus is endemic in many Atlantic salmon farming regions, including Norway, Scotland, Ireland, Canada, and Chile. Prevalence surveys using PCR have detected SGPV in apparently healthy fish, indicating a high rate of subclinical carriage [2].

Diagnosis

Definitive diagnosis of SGPV infection relies on molecular detection combined with histopathology and clinical observation.

Sample Collection

Gill tissue is the sample of choice. Swabs from gill lesions or whole gill arch biopsies preserved in RNAlater or 70% ethanol are suitable for PCR. For histopathology, gill tissue should be fixed in 10% neutral buffered formalin.

Molecular Detection

Real-time quantitative PCR (qPCR) targeting the SGPV DNA polymerase gene or a conserved gene in the central core region is the gold standard. Conventional end-point PCR with gel electrophoresis is also used. The assay has high sensitivity (detection limit ~10 copies per reaction) and specificity. Viral load quantification can be used to correlate with disease severity [1].

Histopathology

Formalin-fixed, paraffin-embedded gill sections stained with hematoxylin and eosin (H&E) show epithelial hyperplasia, lamellar fusion, necrosis, and occasional intracytoplasmic inclusion bodies. Immunohistochemistry (IHC) using anti-SGPV polyclonal or monoclonal antibodies can confirm the presence of viral antigen within lesions.

Electron Microscopy

Transmission electron microscopy (TEM) of negatively stained gill homogenates or ultrathin sections can visualize typical poxvirus virions. This method is useful for initial detection in novel outbreaks [1].

Virus Isolation

SGPV can be propagated in primary salmon gill cell cultures (e.g., AG cells or primary gill epithelial cells) but is challenging due to inconsistent cytopathic effect. Not recommended as a routine diagnostic method [2].

Serology

No commercial serological tests are available. Experimental ELISA and virus neutralization tests have been developed for research purposes [2].

Differential Diagnosis

Several other gill pathogens and non-infectious conditions produce similar clinical and histopathological findings. Key differentials are listed in Table 1.

Table 1: Differential Diagnosis for Salmon Gill Poxvirus-like Lesions

Condition Etiologic Agent Key Distinguishing Features
Amoebic Gill Disease Neoparamoeba perurans Amoebae visible on wet mount; PCR positive; characteristic hyperplastic lesions with amoebae
Ichthyobodosis Ichthyobodo necator Small flagellates on gill smears; more common in freshwater; severe epithelial erosion
Tenacibaculosis Tenacibaculum maritimum Gum-like lesions on gill margins; filamentous bacteria on Gram stain; PCR
Branchiomycosis Branchiomyces sanguinis Fungal hyphae in gill vessels; seasonal association with high organic matter
Proliferative Gill Disease (non-viral) Environmental irritants, low pH, high ammonia Resolution when water quality improves; no viral detection
Atlantic Salmon Reovirus ASRV Histologically shows syncytia; electron microscopy shows reovirus particles; PCR negative for SGPV

For comparative reference to other aquatic viral diseases, see Ichthyophthirius multifiliis (White Spot Disease) in Farmed Fish [1].

Treatment and Control

No antiviral drugs are approved for SGPV in aquaculture. Control relies on management practices:

  • Biosecurity: Strict all-in/all-out production, disinfection of equipment, and fallowing of sites reduce viral load.
  • Water quality: Maintain optimal temperature, dissolved oxygen, and low ammonia/nitrite levels to minimize stress.
  • Vaccination: No commercial vaccine is available. Experimental inactivated and DNA vaccines have shown variable efficacy in trials [2].
  • Immune stimulation: Beta-glucans and other immunostimulants are used empirically to enhance innate resistance.
  • Co-infection management: Control of sea lice and bacterial gill infections reduces overall disease impact.

Public Health Concerns

SGPV is a fish-specific virus with no known zoonotic potential. The virus does not replicate in mammalian cells nor cause disease in humans handling infected fish. No food safety concerns exist; proper cooking destroys the virus. However, the occurrence of SGPV outbreaks can impact aquaculture sustainability and economic viability [1].

Diagnostic Workflow

The following diagram outlines a standard diagnostic algorithm for suspect SGPV cases.

flowchart TD
    A[Clinical suspicion: gill lesions, respiratory distress, mortality], > B[Gill biopsy or gill swab collection]
    B, > C{Initial screening}
    C, > D[Wet mount microscopy for parasites / amoebae]
    D, > E[Histopathology: H&E staining of gill sections]
    E, > F[Observation of epithelial hyperplasia, fusion, inclusions]
    F, > G[Parallel molecular testing: qPCR for SGPV]
    G, > H{Results}
    H, > I[Positive: SGPV confirmed]
    H, > J[Negative: consider other infectious or environmental causes]
    I, > K[Viral load quantification for prognosis]
    J, > L[Additional PCR panels for ASRV, bacteria, etc.]
    K, > M[Management interventions: reduce stress, control co-infections]
    L, > M

References

[1] Noga, E. J. (2010). Fish Disease: Diagnosis and Treatment (2nd ed.). Wiley-Blackwell.

[2] Woo, P. T. K., & Bruno, D. W. (Eds.). (2014). Viral Infections of Fish (3rd ed.). CABI.

[3] Merck & Co. (2024). The Merck Veterinary Manual (12th ed.). Merck Sharpe & Dohme Corp.

[4] Kibenge, F. S. B., & Godoy, M. G. (Eds.). (2016). Aquaculture Virology. Academic Press. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.